¹ÙÀÌ¿ÀÇǵå¹é

 

Contact Us

Ç×»ó °í°´À» À§ÇØ ÃÖ¼±À» ´ÙÇÏ´Â ºê·¹Àξ¾Å©¸´ÀÌ µÇ°Ú½À´Ï´Ù.

  • ´ëÇ¥ÀüÈ­: 1599-8810
  • Æѽº: 02-553-8810
  • ¸ÞÀÏ: info@brainall.co.kr
°ßÀû¹®ÀÇ

CNS Vital Signs ½Å°æÀÎÁö±â´É°Ë»ç

CNS Vital Signs
Computerized Neuropsychological Tests

Àü»êÈ­ ½Å°æÀÎÁö±â´É°Ë»ç

 

CNS Vital Signs˼
ȯÀÚÀÇ ½Å°æ ÀÎÁö »óŸ¦ Æò°¡ÇÏ°í ´Ü¼øÇÑ ¿îµ¿ ¼öÇà ´É·Â ¹× ÁÖÀÇ·Â, ±â¾ï·ÂºÎÅÍ ÁýÇà ±â´É±îÁö ±¤¹üÀ§ÇÑ ¹üÀ§¸¦ ´Ù·ç±â À§ÇÑ °úÇÐÀûÀ¸·Î À¯È¿ÇÏ¸ç °´°üÀûÀÌ°í ¹ÏÀ» ¸¸ÇÑ Àü»êÈ­µÈ ½Å°æ ½É¸® °Ë»ç¸¦ È°¿ë °¡´ÉÇÑ Æò°¡ ÀýÂ÷ÀÌ´Ù. CNS Vital Signs´Â ¶ÇÇÑ 50°³ ÀÌ»óÀÇ Àß ¾Ë·ÁÁø Áõ°Å ±â¹Ý ÀÇ·á ¹× °Ç°­ (Çൿ, Áõ»ó, °øÁ¸ÀÌȯ) Æò°¡ ôµµ¸¦ Æ÷ÇÔÇÏ°í ÀÖ´Ù. ¼ÒÇÁÆ®¿þ¾î°¡ ȯÀÚ Æò°¡ÀÇ Ç¥ÁØÈ­µÈ Á¡¼ö¸¦ Æò°¡ ÈÄ Áï½Ã ÀÚµ¿È­ÇÏ¿© ´Ù¾ç¼º°ú Æò°¡ÀÚ Æí°ßÀ» Á¦°ÅÇÑ´Ù.

Æò°¡ Ç÷§ÆûÀº ¿ä¾à ´ë½Ãº¸µå, °³ÀÎ ÀÀ´ä ±×¸®°í Á¾´ÜÀû °üÁ¡À» Æ÷ÇÔÇÏ°í ÀÖ´Â »ç¿ëÀÚ Ä£È­Àû ±â·ÏÀ» ÀÚµ¿ äÁ¡ÇÏ¸ç »ý¼ºÇÑ´Ù. ½Å°æ ÀÎÁö ±â·ÏÀº °Ë»ç ¿øÁ¡¼ö, ¿¬·É º¸Àü Ç¥ÁØÀ» Æ÷ÇÔÇÑ ¿µ¿ª Á¡¼ö ±×¸®°í ÀüüÀûÀÎ ½Å°æ ÀÎÁö ÁöÇ¥¸¦ Á¦½ÃÇÑ´Ù. ±â·ÏÀÇ Ç¥ÁØÈ­µÈ Á¦½Ã¿Í ±×¿¡ Æ÷ÇÔµÈ µ¥ÀÌÅÍ´Â ÀÓ»óÀÇ°¡ È°µ¿µéÀ» Æò°¡ÇÏ°í °ü¸®ÇÏ´Â °ÍÀ» µÞ¹ÞħÇÑ´Ù.

 

 

 

CNS Vital Signs - Cognitrax °Ë»ç

 

Cognitrax ½Å°æ ÀÎÁö °Ë»ç¶õ ?

Cognitrax´Â CNS Vital Signs ½Å°æÀÎÁö Æò°¡ ±â¼úÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù. 7000¸í ÀÌ»óÀÇ ÀÓ»ó »ç¿ëÀÚ ¹× 52 °³±¹ÀÇ 2000¸í ÀÌ»óÀÇ ÀÓ»ó ¿¬±¸ÀÚ ¹× ¿¬±¸¿øÀÌ Âü¿©ÇÑ ÀÓ»óÀû È°¿ëÀÇ ¼±µÎ ÁÖÀÚÀÔ´Ï´Ù. Cognitrax´Â Àü»êÈ­ µÈ ½Å°æ ½É¸® °Ë»ç¸¦ »ç¿ëÇÏ¿© ȯÀÚÀÇ "ÇÙ½É"½Å°æÀÎÁö ±â´ÉÀ» °´°üÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×°ÍÀº ½Å°æ ÅðÇ༺ Àå¾Ö (¿¹ : MCI - °æÁõÀÎÁö Àå¾Ö, Á¶±â Ä¡¸Å µî)ÀÇ Àνİú Æò°¡¸¦ Áö¿øÇÏ¿© ÀÓ»óÀÇ°¡ ¹Ì¹¦ÇÑ ÀÎÁöÀû °á¼Õ ¹× º¯À̸¦ ŽÁöÇÏ°í ÃßÀûÇϵµ·Ï µµ¿ÍÁÝ´Ï´Ù. Cognitrax´Â ȯÀÚ ½Å°æÀÎÁö±â´ÉÀÇ Á¤È®ÇÑ Á¤½ÅÃøÁ¤¹ý(psychometric- ¹ÝÀÀ ¼Óµµ°¡¾ø°í ÀÀ´ä ¼Óµµ¿Í Á¤È®µµ) ÃøÁ¤À» ÀÚµ¿È­ÇÕ´Ï´Ù. Cognitrax µµ¸ÞÀÎ Á¡¼ö´Â °³º° ÇÏÀ§ Å×½ºÆ®ÀÇ µ¥ÀÌÅÍ °ªÀ» »ç¿ëÇÏ¿© °è»ê µÈ ÇǽÇÇèÀÚ (¿ø) Á¡¼ö, Ç¥ÁØ Á¡¼ö ¹× ¹éºÐÀ§ ¼ö ¼øÀ§·Î Ç¥½ÃµÇ¸ç ¿Ã¹Ù¸¥ ÀÀ´ä ¼ö, À߸øµÈ ÀÀ´ä ¼ö ¹× ¹ÝÀÀ ½Ã°£ÀÔ´Ï´Ù. Cognitrax´Â 8 ¼¼¿¡¼­ 90 ¼¼±îÁöÀÇ ¼ö¸í ±âÁØÀ» °®Ãá ¿¬·É ÀÏÄ¡ ±âÁØ¿¡ ±Ù°ÅÇÑ Àå¾ÖÀÇ ÁßÁõµµ µî±ÞÀ» ¸Å±é´Ï´Ù. Cognitrax´Â ȯÀÚÀÇ ½Å°æ Á¤½Åº´ Áõ»óÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¡°³úÀÇ Áúº´µéÀº ÈçÈ÷ ÀÎÁö ´É·ÂÀÇ Àå¾Ö¸¦ Æ÷ÇÔÇÑ ÇൿÀÇ º¯È­¿Í ½Å°æ Á¤½ÅÇÐÀû Áõ»óµéÀÇ ¹ß»ýÀ» ¾ß±âÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­µéÀÇ Á¸Àç¿Í Ư¼º¿¡ ´ëÇÑ Áö½ÄÀº ½Å°æÇÐÀû Áúº´µé ¹× Á¤½Å ÀÇÇÐÀû Áúº´µéÀ» °¡Áö°í Àִ ȯÀÚµéÀ» Æò°¡ÇÏ°í °ü¸®Çϴµ¥ µµ¿òÀÌ µÇ¸ç ¶ÇÇÑ ±×µé¿¡ ´ëÇÑ Á¾Àû Ä¡·á¿¡µµ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.¡± Neurology 1996;47:592-599 ¿¡¼­ °³ÀÛÇÔ.

³ú ¼º´É °ü¸® ¹× ¸ð´ÏÅ͸µ
»õ·Î¿î °¡ÀÌµå ¶óÀÎÀº ½Å°æÀÎÁöÀû ¿¬¼Ó Æò°¡ÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù. Cognitrax´Â ÀÏ·ÃÀÇ Æò°¡¿¡ ÃÖÀûÈ­µÇ¾î ÀÖ½À´Ï´Ù.

"ÀÎÁöÀû Æò°¡ : ÀÎÁöÀÇ Á¡ÁøÀû °¨¼Ò¿¡ ´ëÇÑ Áõ°Å´Â ¾Õ¿¡¼­ ¾ð±ÞÇßµíÀÌ °³ÀÎÀÌ 'AD¿¡ ÀÇÇÑ MCI'¸¦ °¡Áö°í ÀÖ´Ù´Â Ãß°¡ÀûÀÎ Áõ°Å¸¦ Á¦°øÇϹǷΠ°¡´ÉÇÒ ¶§¸¶´Ù ÀÎÁöÀÇ Àå±âÀû Æò°¡¸¦ ¾ò´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÌ Á¤º¸ÀÇ ÇýÅÃÀ» ¹ÞÁö ¾Ê°íµµ Áø´ÜÀ» ³»¸± ¼ö ÀÖÀ½À» ÀÎÁ¤ÇÏÁö¸¸ ±×·¯³ª ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀÎÁöÀÇ Á¡ÁøÀûÀÎ °¨¼Ò¿¡ ´ëÇÑ °´°üÀûÀÎ Áõ°Å¸¦ ¾ò´Â °ÍÀº Áø´ÜÀÇ Á¤È®¼ºÀ» È®¸³ÇÏ°í ÀáÀçÀûÀÎ Ä¡·á ¹ÝÀÀÀ» Æò°¡ÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù. " Ãâó : Alzheimer & Dementia - (2011) 1-10; ¾ËÃ÷ÇÏÀÌ¸Ó º´À¸·Î ÀÎÇÑ °æÁõ ÀÎÁö ±â´É Àå¾Ö Áø´Ü : ³ëÈ­ ¹æÁö ¹× ¾ËÃ÷ÇÏÀÌ¸Ó º´ ¿¬±¸ ±×·ìÀÇ ±ÇÀå »çÇ×.

 

 

CNS Vital Signs - Çؼ® °¡À̵å

 

CNS Vital Signs ÇýÅà ¹× Ư¡

CNS Vital SignsÀÇ ÇýÅà ¹× Ư¡:

  • °úÇÐÀûÀ¸·Î Ÿ´çÇÏ°í ½Å·Ú¼º ÀÖ´Â °Ë»ç
  • 1000ºÐÀÇ 1ÃÊ ´ÜÀ§ÀÇ Á¤¹Ð¼º
  • 50°³ ÀÌ»óÀÇ ¾ð¾î Áö¿ø
  • º¯µ¿À» ¹èÁ¦Çϴ ǥÁØÈ­µÈ °Ë»ç ÁýÇà ¹× Ã¤Á¡
  • Á¾ÀÌ ¶Ç´Â ÀüÀÚ µ¥ÀÌÅÍ ¼öÁý ¿É¼Ç
  • ÃÖ¼ÒÀÇ Æò°¡ÀÚ ±³À° ÇÊ¿ä
  • °£´ÜÇÑ Çϵå¿þ¾î ÇÊ¿ä Á¶°Ç (¿¹, À©µµ¿ì ±â¹Ý PC)
  • ÀÎÅͳݿ¡¼­ ÀÌ¿ë °¡´ÉÇϳª ÀÎÅͳݿ¡ ÀÇÁ¸ÀûÀÌÁö ¾ÊÀ½
  • »çÀÌÆ®³ª Áø·á¼Ò°¡ »ç¿ëÇϱ⿡ ±²ÀåÈ÷ Æí¸®ÇÔ
  • Áï°¢ÀûÀÌ°í ÀÚµ¿È­µÈ °Ë»ç ÈÄ Ã¤Á¡; ¸ðµç äÁ¡Àº ÀÎÅͳÝÀ¸·Î ÆÄÀÏÀ» º¸³¾ ÇÊ¿ä ¾øÀÌ ÀÚüÀûÀ¸·Î ÀÌ·ç¾îÁü
  • ȯÀÚÀÇ ¼ö¿ë¼º - °Ë»ç´Â ÀÌÇØÇϱ⠽±°í °£´ÜÇϸç ȯÀڵ鿡°Ô Àß ¹Þ¾Æµé¿©Áü
  • ¿¬±¸ ÇÊ¿ä Á¶°Ç¿¡ µû¶ó ¹èÅ͸® »ç¿ëÀ» Á¶Á¤ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ÇÁ·ÎÁ§Æ®¿¡ ÇÊ¿äÇÑ ¿µ¿ª¿¡ ¸Â°Ô ¼³°è°¡´ÉÇÑ ¸ÂÃãÇü °Ë»ç
  • ¸ÂÃãÇü µî±ÞÁ¦ ¹× Áõ»ó ôµµ¸¦ ¹èÅ͸®¿¡ ½±°Ô Ãß°¡ÇÒ ¼ö ÀÖÀ½
  • 50°³ ÀÌ»óÀÇ ¾ð¾î Áö¿ø

 

CNS Vital SignsÀÇ CORE ÀÓ»ó ¹èÅ͸®(Cognitrax)´Â

ÀÓ»óÀÇ°¡ ±×µé ȯÀÚÀÇ ½Å°æ ÀÎÁö ±â´ÉÀ» Áï°¢ÀûÀ¸·Î Æò°¡ÇÏ±æ ¿øÇÒ ¶§ ÀϹÝÀûÀÎ ½Å°æ ½É¸® Æò°¡ÀÇ ÀϺγª °á¼ÕÀÇ ±âÁؼ± ¹× Ư¡¿¡ ´ëÇÑ ´Üµ¶ ¹èÅ͸®·Î½á »ç¿ëµÇ±â À§ÇÑ °ÍÀÔ´Ï´Ù;
¶ÇÇÑ, CNS Vital Signs´Â EEG Àåºñ(QEEG or NEUROFEEDBACK)°úÀÇ ¿¬°á¿¡ ´ëÇÑ º¹ÇÕÀûÀÎ Æò°¡°¡ ÇÊ¿äÇÑ °æ¿ì EEG Àåºñµé°ú °Ë»ç°á°ú¸¦ ¿¬°áÇؼ­ Á¾ÇÕÀûÀ¸·Î Æò°¡µÉ ¼ö ÀÖ½À´Ï´Ù. º¸Åë ´Ù¸¥ Æò°¡¿Í ÇÔ²² ¾²¿©Áö°í ÀÖ½À´Ï´Ù.

CNS Vital Signs Æò°¡ µµ±¸´Â ÈçÈ÷ ÃÖÃÊÀÇ È¯ÀÚ µî·Ï ÀýÂ÷·Î½á »ç¿ëµÇ°Å³ª »ó¼¼ÇÑ ½Å°æ ½É¸®ÇÐÀû Æò°¡ ¹× CT ÃÔ¿µ, fMRI, PET, EEG, SPECT ÃÔ¿µ°ú °°Àº ´Ù¸¥ ÀýÂ÷µéÀ» Æ÷ÇÔÇÒ ¼ö ÀÖ´Â ÀüüÀûÀÌ°í Á¾ÇÕÀûÀÎ ½Å°æÇлó ¶Ç´Â Á¤½Å°úÀû Æò°¡ÀÇ ÀÏºÎ·Î½á »ç¿ëµË´Ï´Ù.

´Ü, CNS VS´Â ƯÁ¤ ÀÎÁö Àå¾Ö³ª Á¾ÇÕÀûÀÎ ½Å°æ ÀÎÁö Æò°¡¿¡ ´ëÇÑ ´õ¿í öÀúÇÑ ½É¸®Àû ºÐ¼®À» ´ëüÇÏÁö´Â ¾Ê½À´Ï´Ù.

 

 

CNS Vital SignsÀ» ÀÌ¿ëÇÑ ½Å°æÀÎÁö°Ë»ç

½Å°æÀÎÁö¿µ¿ª ¹× ½É°¢¼º Æò°¡

 

 

 

 

CNS Vital SignsÀ» ÀÌ¿ëÇÑ ½Å°æÀÎÁö º´¸®Æò°¡

¾Ï½ÃÀûÀÎ º´¸® ÆÐÅÏÆò°¡

 

 

Àü »ý¾Ö ½Å°æÀÎÁöÆò°¡¿Í ºñÀü

 

 

CNS Vital Signs ¸ÂÃãÇü ¼Ö·ç¼Ç

Ç÷§Æû È°¿ë

 

 

CNS Vital Signs À¥±â¹Ý Æò°¡ ÇÁ·Î±×·¥

°Ë»ç ÇÁ·Î¼¼¼­

 

 

CNS Vital Signs ÀÓ»ó »ç·Ê ¹× È°¿ë ¿¹

AD/HD°áÇÌ È¯ÀÚ Æ¯¼º

 

 

AD/HD Æò°¡ Çʿ伺

 

 

Æĺ´ ±ºÀÎ ¿Ü»ó¼º ³ú¼Õ»ó(TBI)¤ý¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö(PTSD) ÀÎÁö·Â ȸº¹ ÃßÀû Æò°¡

 

CNS Vital Signs Æò°¡ °¡ÁõÇÑ ½Å°æÀÎÁöÀû ÀÓ»óº´¸®

Cognitrax Ä¡¸Å ȯÀÚ Æò°¡

Ä¡¸Å ȯÀÚ¸¦ À§ÇÑ Æò°¡

 

 

Cognitrax´Â Àü»êÈ­ µÈ ½Å°æ ½É¸® °Ë»ç¸¦ »ç¿ëÇÏ¿© ȯÀÚÀÇ "ÇÙ½É"½Å°æÀÎÁö ±â´ÉÀ» °´°üÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×°ÍÀº ½Å°æ ÅðÇ༺ Àå¾Ö (¿¹ : MCI - °æÁõÀÎÁö Àå¾Ö, Á¶±â Ä¡¸Å µî)ÀÇ Àνİú Æò°¡¸¦ Áö¿øÇÏ¿© ÀÓ»óÀÇ°¡ ¹Ì¹¦ÇÑ ÀÎÁöÀû °á¼Õ ¹× º¯À̸¦ ŽÁöÇÏ°í ÃßÀûÇϵµ·Ï µµ¿ÍÁÝ´Ï´Ù. Cognitrax´Â ȯÀÚ ½Å°æÀÎÁö±â´ÉÀÇ Á¤È®ÇÑ Á¤½ÅÃøÁ¤¹ý(psychometric- ¹ÝÀÀ ¼Óµµ°¡¾ø°í ÀÀ´ä ¼Óµµ¿Í Á¤È®µµ) ÃøÁ¤À» ÀÚµ¿È­ÇÕ´Ï´Ù. Cognitrax µµ¸ÞÀÎ Á¡¼ö´Â °³º° ÇÏÀ§ Å×½ºÆ®ÀÇ µ¥ÀÌÅÍ °ªÀ» »ç¿ëÇÏ¿© °è»ê µÈ ÇǽÇÇèÀÚ (¿ø) Á¡¼ö, Ç¥ÁØ Á¡¼ö ¹× ¹éºÐÀ§ ¼ö ¼øÀ§·Î Ç¥½ÃµÇ¸ç ¿Ã¹Ù¸¥ ÀÀ´ä ¼ö, À߸øµÈ ÀÀ´ä ¼ö ¹× ¹ÝÀÀ ½Ã°£ÀÔ´Ï´Ù. Cognitrax´Â 8 ¼¼¿¡¼­ 90 ¼¼±îÁöÀÇ ¼ö¸í ±âÁØÀ» °®Ãá ¿¬·É ÀÏÄ¡ ±âÁØ¿¡ ±Ù°ÅÇÑ Àå¾ÖÀÇ ÁßÁõµµ µî±ÞÀ» ¸Å±é´Ï´Ù. Cognitrax´Â ȯÀÚÀÇ ½Å°æ Á¤½Åº´ Áõ»óÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

 

 

CNS Vital Signs Æò°¡ Ç÷§Æû

 

 

 

CNS Vital Signs ½Å·Ú¼º ¹× Ÿ´çµµ °ËÅä ¹× Çмú¿¬±¸ ³í¹® ¹ßÇ¥ ÃâÆǹ°

CNS Vital Signs ½Å·Ú¼º ¹× Ÿ´çµµ °ËÅä

Çмú¿¬±¸ ³í¹® ¹ßÇ¥ ÃâÆǹ° - ³í¹®ÀڷẸ±â

Other Publications and Scientific Posters:

 

CORRELATIONS BETWEEN PHYSICAL ACTIVITY AND NEUROCOGNITIVE DOMAIN FUNCTIONS IN PATIENTS WITH SCHIZOPHRENIA; BMC Psychiatry: (2017) 17:4; Kurebayashi and Otaki (article)

Driving after Concussion: Is It Safe To Drive after Symptoms Resolve? Driving after Concussion: Is It Safe To Drive after Symptoms Resolve? Schmidt Julianne D., Hoffman Nicole L., Ranchet Maud, Miller L. Stephen, Tomporowski Phillip D., Akinwuntan Abiodun E., and Devos Hannes. Journal of Neurotrauma. January 2017,. PMID:27959745 DOI:10.1089/neu.2016.4668

NEUROCOGNITIVE AND EXECUTIVE FUNCTIONING IN ADULT SURVIVORS OF CONGENITAL HEART DISEASE; Congenit Heart Dis. 2016 Sep 21; Klouda L, Franklin WJ, Saraf A, Parekh DR, Schwartz DD.

RANDOMIZED DOUBLE-BLIND COMPARISON OF COGNITIVE AND EEG EFFECTS OF LACOSAMIDE AND CARBAMAZEPIN; Epilepsy Behav. 2016 Sep;62:267-75; Meador KJ, Loring DW, Boyd A, Echauz J, LaRoche S, Velez-Ruiz N, Korb P, Byrnes W, Dilley D, Borghs S, De Backer M, Story T, Dedeken P, Webster E.

A COMPARISON OF COGNITIVE FUNCTION IN FORMER RUGBY UNION PLAYERS COMPARED WITH FORMER NON-CONTACT SPORT PLAYERS AND THE IMPACT OF CONCUSSION HISTORY; Sports Med. 2016 Aug 24; Hume PA, Theadom A, Lewis GN, Quarrie KL, Brown SR, Hill R, Marshall SW.

A PHASE 1 STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TAK-063, A SELECTIVE PDE10A INHIBITOR; Psychopharmacology (Berl). 2016 Aug 30; Tsai M, Chrones L, Xie J, Gevorkyan H, Macek TA.

THE EFFECTS OF DESVENLAFAXINE ON NEUROCOGNITIVE AND WORK FUNCTIONING IN EMPLOYED OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDERS; J Affect Disord. 2016 May 31;203:55-61; Lam RW, Iverson GL, Evans VC, Yatham LN, Stewart K, Tam EM, Axler A, Woo C.

ASSESSMENT OF NEUROCOGNITIVE FUNCTIONS IN CHILDREN AND ADOLESCENTS WITH OBESITY; Appl Neuropsychol Child. 2016 May 16:1-7; Bozkurt H, Özer S, Y©¥lmaz R, Sönmezgöz E, Kazanc©¥ Ö, Erbaş O, Demir O.

PERSISTENT PROBLEMS 1 YEAR AFTER MILD TRAUMATIC BRAIN INJURY: A LONGITUDINAL POPULATION STUDY IN NEW ZEALAND; Br J Gen Pract. 2016 Jan;66(642):e16-23; Theadom A, Parag V, Dowell T, McPherson K, Starkey N, Barker-Collo S, Jones K, Ameratunga S, Feigin VL; BIONIC Research Group.

COGNITION IN THE EMERGENCY DEPARTMENT AS A PREDICTOR OF RECOVERY AFTER PEDIATRIC MILD TRAUMATIC BRAIN INJURY; J Int Neuropsychol Soc. 2016 Jan 20:1-9; Brooks BL, Daya H, Khan S, Carlson HL, Mikrogianakis A, Barlow KM.

PERSISTENT COGNITIVE CHANGES IN BREAST CANCER PATIENTS 1 YEAR FOLLOWING COMPLETION OF CHEMOTHERAPY; J Int Neuropsychol SoC. 2014 Apr;20(4):370-9; Collins B, Mackenzie J, Tasca GA, Scherling C, Smith A.

NEUROPSYCHOLOGICAL OUTCOME AND ITS CORRELATES IN THE FIRST YEAR AFTER ADULT TRAUMATIC BRAIN INJURY: A POPULATIOB-BASED NEW ZEALAND STUDY; Brain Inj. 2015 Dec;29(13-14):1604-16; Barker-Collo S, Jones K, Theadom A, Starkey N, Dowell A, McPherson K, Ameratunga S, Dudley M, Te Ao B, Feigin V; BIONIC Research Group.

EFFECTS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AND STIMULANT MEDICATION ON CONCUSSION SYMPTOM REPORTING AND COMPUTERIZED NEUROCOGNITIVE TEST PERFORMANCE; Arch Clin Neuropsychol. 2015 Nov;30(7):683-93; Littleton AC, Schmidt JD, Register-Mihalik JK, Gioia GA, Waicus KM, Mihalik JP, Guskiewicz KM

THE CLINICAL UTILITY OF A CONCUSSION REBASELINE PROTOCOL AFTER CONCUSSION RECOVERY; Clin J Sport Med. 2015 Nov 17; Lynall RC, Schmidt JD, Mihalik JP, Guskiewicz KM

THALAMIC ATROPHY PREDICTS COGNITIVE IMPAIRMENT IN RELAPSING REMITTING MULTIPLE SCLEROSIS. EFFECT ON INSTRUMENTAL ACTIVITIES OF DAILY LIVING AND EMPLOYMENT STATUS; J Neurol Sci. 2015 Nov 15;358(1-2):236-42; Papathanasiou A, Messinis L, Zampakis P, Panagiotakis G, Gourzis P, Georgiou V, Papathanasopoulos P

EVALUATION OF EXECUTIVE FUNCTIONS IN CHILDREN AND ADOLESCENTS WITH FAMILIAL MEDITERRANEAN FEVER; Child Neuropsychol. 2015 Nov 12:1-11; Özer S, Bozkurt H, Y©¥lmaz R, Sönmezgöz E, Bütün I

TEST-RETEST RELIABILITY OF A COMPUTERIZED CONCUSSION TEST: CNS VITAL SIGNS; Sports Health. 2015 Sep;7(5):443-7; Littleton AC, Register-Mihalik JK, Guskiewicz KM.

ADULTS WITH SICKLE CELL DISEASE MAY PERFORM COGNITIVE TESTS AS WELL AS CONTROLS WHEN PROCESSING SPEED IS TAKEN INTO ACCOUNT: A PRELIMINARY CASE-CONTROL STUDY; J Adv Nurs. 2015 Aug 20; Crawford RD, Jonassaint CR

DECREASING AD/HD PHENOTYPIC HETEROGENEITY: SEARCHING FOR NEUROBIOLOGICAL UNDERPINNINGS OF THE RESTRICITIVE INATTENTIVE PHENOTYPE; Eur Child Adolesc Psychiatry. 2015 Jun 10; Ercan ES, Suren S, Bacanl A, Yazici KU, Call C, Ozyurt O, Aygunes D, Kosova B, Franco AR, Rohde LA

DOES A PASSIVE THIRD PARTY OBSERVER OR PROCTOR INFLUENCE SCORES DURING NEUROCOGNITIVE TESTING? Innov Clin Neurosci. 2015 May-Jun; 12(SupplB): 1-20; Bender K, Morgan D, Boyd A

COMPARITIVE COGNITIVE EFFECTS OF LACOSAMIDE VERSUS CARBAMAZEPINE; 2015 American Academy of Neurology; David Loring, Kimford Meador, Alan Boyd, William Byrnes, Deanne Dilley, Simon Borghs, Marc De Backer, Tyler Story, Peter Dedeken, Elizabeth.

REM SLEEP WITHOUT ATONIA SEVERITY PREDICTS COGNITIVE IMPAIRMENT IN REM SLEEP BEHAVIOR DISORDER; 2015 American Academy of Neurology; David J. Sandness, Erik St. Louis, Stuart McCarter, Bradley Boeve, Michael Silber Rochester, MN, USA.

COGNITIVE PERFORMANCE IN A PLACEBO-CONTROLLED PHARMACOTHERAPY TRIAL FOR YOUTH WITH MARIJUANA DEPENDENCE; Addict Behav. 2015 Jun;45:119-23; Roten A, Baker NL, Gray KM.

ACUTE HYPOXIC GAS BREATHING SEVERELY IMPAIRS COGNITION AND TASK LEARNING IN HUMANS; Physiol Behav. 2015 Apr 1;142:104-10; Turner CE, Barker-Collo SL, Connell CJ, Gant N

NEUROCOGNITIVE IMPAIRMENT IN CORTICOSTEROID-NAIVE PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A PROSPECTIVE STUDY; J Rheumatol. 2015 Mar;42(3):441-8; Nishimura K, Omori M, Katsumata Y, Sato E, Gono T, Kawaguchi Y, Harigai M, Mimura M, Yamanaka H, Ishigooka J.

HOMOCYSTEINE AND COGNITIVE DISORDERS OF POSTMENOPAUSAL WOMEN MEASURED BY A BATTERY OF COMPUTER TESTS - CENTRAL NERVOUS SYSTEM VITAL SIGNS; Arch Womens Ment Health. 2015 Mar 31; Raszewski G, Loroch M, Owoc A, Łukawski K, Filip R, Bojar I.

COGNITIVE IMPROVEMENT IN MENINGIOMA PATIENTS AFTER SURGERY: CLINICAL RELEVANCE OF COMPUTERIZED TESTING; J Neurooncol. 2015 Feb;121(3):617-25; Meskal I, Gehring K, van der Linden SD, Rutten GJ, Sitskoorn MM

ARE COGNITIVE FUNCTIONS IN POSTMENOPAUSAL WOMEN RELATED WITH THE CONTENTS OF MACRO-AND MICRO-COMPONENTS IN THE DIET?; Ann Agric Environ Med. 2015 Feb 24;22(1):178-84; Bojar I, Wierzbińska-Stępniak A, Witczak M, Raczkiewicz D, Owoc A.

MUTIPLE PAST CONCUSSIONSARE ASSOCIATED WITH ONGOING POST-CONCUSSIVE SYMPTOMS BUT NOT COGNITIVE IMPAIRMENT IN ACTIVE DUTY ARMY SOLDIERS; Journal of Neurotrauma, 2015 Sep 1;32(17):1301-6 Michael N. Dretsch, Ph.D. Noah D. Silverberg, Ph.D. Grant L. Iverson, Ph.D.

REPEATED HEAD TRAUMA IS ASSOCIATED WITH SMALLER THALAMIC VOLUMES AND SLOWER PROCESSING SPEED: THE PROFESSIONAL FIGHTERS' BRAIN HEALTH STUDY; British Journal Sports Medicine 29 January 2015; C Bernick, S Banks, W Shin, N Obuchowski, S Butler, M Noback, M Phillips, M Lowe, S Jones, M Modic.

BRIEF COGNITIVE AND BEHAVIORAL SCREENING IN CHILDREN WITH NEW-ONSET EPILEPSY: A PILOT FEASIABILITY TRIAL; Pediatr Neurol. 2015 Jan; 52(1):49-55; Triplett RL, Asato MR.

LOGISTIC REGRESSION FUNCTION FOR DETECTION OF SUSPICIOUS PERFORMANCE DURING BASELINE EVALUATIONS USING CONCUSSION VITAL SIGNS; Appl Neuropsychol Adult. 2015;22(3):233-40; Hill BD, Womble MN, Rohling ML.

NEUROCOGNITIVE PERFORMANCE AS A FUNCTION OF RIGHT-SIDED, LOW FREQUENCY rTMS ADMINISTRATION IN TREATMENT RESISTANT DEPRESSION USING CNS VITAL SIGNS; November 2014 National Academy of Neuropsychology Annual Conference; Chappell, A. J., Neumann, S. A., Sayegh, P. A., Seagly, K., Bayan, S., Okwara, L.

PROOF-OF-CONCEPT RANDOMIZED CONTROLLED STUDY OF COGNITION EFFECTS OF THE PROPRIETARY EXTRACT Sceletium tortuosum (Zembrin) TARGETING PHOSPHODIESTERASE-4 IN COGNITIVELY HEALTHY SUBJECTS: IMPLICATIONS FOR ALZHEIMER'S DEMENTIA; Evidence-Based Complementary and Alternative Medicine 2014, Article ID 682014; Simon Chiu, Nigel Gericke, Michel Farina-Woodbury, Vladimir Badmaev, Hana Raheb, Kristen Terpstra, Joalex Antongiorgi, Yves Bureau, Zack Cernovsky, Jirui Hou, Veronica Sanchez, Marissa Williams, John Copen, Mariwan Husni, and Liz Goble.

NEUROCOGNITIVE EVALUATION OF ADULTS WITH CONGENITAL HEART DISEASE: The NICHE STUDY; JACC April 1, 2014 Volume 63, Issue 12; Wayne J. Franklin, Leda Kloudas, Anita Saraf, Melissa Karlsten, Dhaval Parekh, David D. Schwartz, Baylor College of Medicine, Houston, TX, USA, Texas Children's Hospital, Houston, TX, USA

COGNITIVE IMPROVEMENT IN MENINGIOMA PATIENTS AFTER SURGERY: CLINICAL RELEVANCE OF COMPUTERIZED TESTING; J Neurooncol. 2014 Dec 11; Meskal I, Gehring K, van der Linden SD, Rutten GJ, Sitskoorn MM.

A DOUBLE-BLIND, PLACEBO-CONTROLLED INTERVENTION TRIAL OF 3 AND 10 MG SUBLINGUAL MELATONIN FOR POST-CONCUSSION SYNDROME IN YOUTHS (PLAYGAME): STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL; Trials 2014, 15:271; K Barlow, B Brooks, F MacMaster, A Kirton, T Seeger, M Esser, S Crawford, A Nettel-Aguirre, R Zemek, M Angelo, V Kirk, C Emery, D Johnson, M Hill, J Buchhalter, B Turley, L Richer, R Platt, J Hutchison, and D Dewey

I JUST WANT MY RESEARCH CREDIT: FREQUENCY OF SUBOPTOMIAL EFFORT IN A NON-CLINICAL HEALTHY UNDERGRADUATE SAMPLE; Clin Neuropsychol. 2014 Dec 10:1-17; DeRight J, Jorgensen RS.

PROOF-OF-CONCEPT RANDOMIZED CONTROL STUDY OF COGNITION EFFECTS OF THE PROPRIETARY EXTRACT SCELETIUM TORTUOSUM (ZEMBRIN) TARGETING PHOSPHODIESTERASE-4 COGNITIVLY HEALTHY SUBJECTS: IMPLICATIONS FOR ALZHEIMERS'S DEMENTIA; Evid Based Complement Alternat Med. 2014; Chiu S, Gericke N, Farina-Woodbury M, Badmaev V, Raheb H, Terpstra K, Antongiorgi J, Bureau Y, Cernovsky Z, Hou J, Sanchez V, Williams M, Copen J, Husni M, Goble L.

ARE TOUCH SCREEN DEVICES APPROPRIATE FOR NEUROCOGNITIVE TESTING?; ISCTM Winter 2014; J Wei, D Morgan, A Boyd.

NEUROCOGNITIVE DYSFUNCTION IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA PATIENTS: UTILIZATION OF STANDARDIZED COMPUTERIZED NEUROCOGNITIVE TESTING; Katherine B. Peters, Sarah Woodring, Mary L. Affronti, Stevie Threatt, Scott Lindhorst, Danijela Levacic, Annick Desjardins, Tulika Ranjan, Gordana Vlahovic, Allan Friedman, Henry S. Friedman; Duke University Medical Center, Durham, NC; November 2014

ILLNESS SEVERITY, TRAIT ANXIETY, COGNITIVE IMPAIRMENT AND HEART RATE VARIABILITY IN BIPOLAR DISEASE; Psychiatry Res. 2014 Dec 30;220 (3):890-5; Levy B.

NEUROCOGNITION IN THE EMERGENCY DEPARTMENT AFTER A MILD TRAUMATIC BRAIN INJURY IN YOUTH; J Neurotrauma. 2014 Oct 15;31(20):1744-9; Brooks BL, Khan S, Daya H, Mikrogianakis A, Barlow KM.

B-69 COGNITIVE PERFORMANCE AS A FUNCTION OF LOW-FREQUENCY, REPETITIVE, TRANSCRANIAL STIMULATION ADMINISTRATION TO THE RIGHT DORSOLATERAL PREFRONTAL CORTEX ND SUPPLEMENTARY MOTOR AREA; Arch Clin Neuropsychol. 2014 Sep;29(6):562-3; Chappell A, Seagly K, Okwara L, Bayan S, Sayegh P, Neumann S.

A-09 PROCESSING SPEED AND CRITICAL FLICKER FUSION AS MEDIATORS OF AGE AND COGNITION; Arch Clin Neuropsychol. 2014 Sep;29(6):506-7; Mewborn C, Duda B, Lindbergh C, Terry D, Puente A, Bovier E, Shon D, Chu K, Washington T, Stapley L, Hammond B, Renzi L, Miller L.

EMBEDDED VALIDITY INDICATORS ON CNS VITAL SIGNS IN YOUTH WITH NEUROLOGICAL DIAGNOSES; Arch Clin Neuropsychol. 2014 Aug;29(5):422-31; Brooks BL, Sherman EM, Iverson GL.

COMPUTERIZED NEUROCOGNITIVE TEST (CNT) IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE; Dement Neuropsychol 2014 June; 8 (2):112-116; Maira Okada de Oliveira, Sonia Maria Dozzi Brucki.

RELATIONSHIP BETWEEN EXERCISE BEHAVIOR, CARDIORESPIRATORY FITNESS, AND COGNITIVE FUNCTIONIN EARLY BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY: A PILOT STUDY; Appl Physiol Nutr Metab. 2014 Jun;39(6):724-9; Crowgey T, Peters KB, Hornsby WE, Lane A, McSherry F, Herndon JE 2nd, West MJ, Williams CL, Jones LW.

ASSESSMENT OF COGNITIVE PERFORMANCE USING CNS VITAL SIGNS AFTER ELECTROCONVULSIVE TREATMENT OF SCHIZOPHRENIA; J ECT. 2014 Mar;30(1):e5-6; Wysokiński A, Dzienniak M, Kłoszewska I.

MINIMAL GENDER DIFFERENCES ON THE CNS VITAL SIGNS COMPUTERIZED NEUROCOGNITIVE BATTERY; Appl Neuropsychol Adult. 2014;21(1):36-42; Iverson GL, Brooks BL, Ashton Rennison VL.

THE SELECTIVE GLYCINE UPTAKE INHIBITOR ORG 25935 AS AN ADJUNCTIVE TREATMENT TO ATYPICAL ANTIPSYCHOTICS IN PREDOMINANT PERSISTENT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: RESULTS FROM THE GIANT TRIAL; Journal of Clinical Psychopharmacology: April 2014 - Volume 34 - Issue 2 - p 190-198; Schoemaker, Jansen, Schipper, Szegedi

COGNITIVE FUNCTIONS, ApoE POLYMORPHISM AND HORMONAL REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN; APA New York 2014;Iwona Bojar, Mariusz Gujski, Dorota Raczkiewicz and Kasia Gustaw Rothenberg

COGNITIVE DEFICITS IN PATIENTS WITH TRIGEMINAL NEURALGIA: OPPORTUNITIES TO IMPROVE CARE AND QUALITY OF LIFE; Acta Neurochir (Wien). 2014 May 9; Meskal I, Rutten GJ, Beute GN, Salden ME, Sitskoorn MM.

COGNITIVE IMPAIRMENT IN RELAPSING REMITTING AND SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS PATIENTS: EFFICACY OF A COMPUTERIZED COGNITIVE SCREENING BATTERY; ISRN Neurology March 2014; Athanasios Papathanasiou, Lambros Messinis, Vasileios L. Georgiou, and Panagiotis Papathanasopoulos

THE PROTECTIVE EFFECT OF EDUCATION ON COGNITION IN PROFESSIONAL FIGHTERS; Arch Clin Neuropsychol. 2014 Feb;29(1):54-9; Banks S, Obuchowski N, Shin W, Lowe M, Phillips M, Modic M, Bernick C.

THE EFFECTS OF VISUAL AND SENSORY PERFORMANCE ON HEAD IMPACT BIOMECHANICS IN COLLEGE FOOTBALL PLAYERS; Annals of Biomedical Engineering January 2014, Volume 42; Jacqueline A. Harpham, Jason P. Mihalik, Ashley C. Littleton, Barnett S. Frank, Kevin M. Guskiewicz

COGNITIVE IMPAIRMENT IN MULTIPLE SCLEROSIS PATIENTS: VALIDITY OF A COMPUTERIZED COGNITIVE SCREENING BATTERY; 2014 EFNS European Journal of Neurology 21 (Suppl. 1), 104-387; A. Papathanasioul, L. Messinis, V. Georgiou, P. Gourzis, P. Papathanasopoulos

CURRENT CONCEPTS IN SPORT CONCUSSION MANAGEMENT: A MULTIFACETED APPROACH; Journal of Sport and Health Science 2 (2013, December) 227-235; A Littleton, K Guskiewicz

WHAT BOXING TELLS US ABOUT REPETITIVE HEAD TRAUMA AND THE BRAIN; Alzheimer's Research & Therapies. 2013; 5(3): 23; Charles Bernick, Sarah Banks

OUTCOMES, UTILITY, AND FEASIBILITY OF A SINGLE TASK AND DUAL TASK INTERVENTION PROGRAMS: PRELIMINARY IMPLICATIONS FOR POST-CONCUSSION REHABILITATION; J Sci Med Sport. 2013 Nov 28. Ingriselli JM, Register-Mihalik JK, Schmidt JD, Mihalik JP, Goerger BM, Guskiewicz KM.

PREDICTING CLINICAL CONCUSSION MEASURES AT BASELINE BASED ON MOTIVATION AND ACADEMIC PROFILE; Clin J Sport Med. 2013 Nov;23(6):462-9; Trinidad KJ, Schmidt JD, Register-Mihalik JK, Groff D, Goto S, Guskiewicz KM.

INTERMITTENT FASTING REDUCES ABDOMINAL OBESITY AND IMPROVES COGNITIVE FUNCTION IN OBESE ADULTS; OBESITY 2013 POSTER ABSTRACTS NOVEMBER 15, 2013; Sarah Brannon, Edward L. Melanson, Wendolyn Gozansky, Bronwen Martin, Mark Mattson, Rui Wang, William T. Donahoo

EFFECT OF METABOLIC ABNORMALITIES ON COGNITIVE PERFORMANCE AND CLINICAL SYMPTOMS IN SCHIZOPHRENIA; Archives of Psychiatry and Psychotherapy, 2013; 4 : 13-25; Adam Wysokiński, Małgorzata Dzienniak, Iwona Kłoszewska

TEST-RETEST RELIABILITY OF FOUR COMPUTERIZED NEUROCOGNITIVE ASSESSMET TOOLS IN AN ACTIVE DUTY MILITARY POPULATION; Arch Clin Neuropsychol. 2013 Nov;28(7):732-42.; Cole WR, Arrieux JP, Schwab K, Ivins BJ, Qashu FM, Lewis SC.

ESTABLISHING A COMPUTERIZED TOOL FOR CLINICAL EVALUATION OF COGNITIVE FUNCTION IN CHILDREN WITH NEW-ONSET EPILEPSY; American Epilepsy Society 2013; M. Asato, R. Triplett, J. Pardini, P. Beem, D. Magovern

COGNITIVE PERFORMANCE IS IMPAIRED IN EUTHYMIC CHINESE PATIENTS WITH BIPOLAR 1 DISORDER; J Affect Disord. 2013 Oct; 151 (1):156-63.; Eric YW, Halari R, Cheng KM, Leung SK, Young AH.

DISCUSS THE DIAGNOSIS AND SIGNIFICANCE OF COVERT HEPATIC ENCEPHALOPATHY; The Egyptian Journal of Internal Medicine Sept. 2013, 25:232-236; Hoda Atya

THE EFFECTS OF SLEEP QUALITY AND SLEEP QUANTITY ON CONCUSSION BASELINE ASSESSMENT; Clin J Sport Med. 2013 Sep;23(5):343-8.; Mihalik JP, Lengas E, Register-Mihalik JK, Oyama S, Begalle RL, Guskiewicz KM.

COGNITIVE EFFECTS OF CHEMOTHERAPY IN BREAST CANCER PATIENTS: A DOSE RESPONSE STUDY; Psycho Oncology. 2013 Jul;22(7):1517-27; Collins B, MacKenzie J,Tasca GA, Scherling C, Smith A

PROFESSIONAL FIGHTERS BRAIN HEALTH STUDY: RATIONALE AND METHODS; Am J Epidemiol. 2013 Jul 15;178(2):280-6; Bernick C, Banks S, Phillips M, Lowe M, Shin W, Obuchowski N, Jones S, Modic M.

THE EFFECTS OF CARDIOVASCULAR EXERCISE ON COGNITIVE FUNCTION IN INDIVIDUALS WITH PARKINSON'S DISEASE (PD); Movement Disorders June 2013 Sydney, Australia; McCamish, J., Samson, A., Vrongistinos, K., Jung, T.

IS ADHD RESTRICTIVE SUB-TYPE, WHICH IS SPECIFIED BY DSM-V A VALID DIAGNOSIS? HOLISTIC ASSESSMENT WITH EXECUTIVE FUNCTIONS, GENETIC, AND MULTIMODAL BRAIN IMAGING METHODS; 4th World Congress on ADHD From Childhood to Adult Disease June 2013 Milan Italy (Top Poster Award); Serkan Süren, Kemal Utku Yazici, Ali Bacanli, Cem Çalli, Duygu Aygünes, Buket Kosava, Cahide Aydin, Eyüp Sabri Ercan

PROFILE OF A NEWLY DIAGNOSED PERSON WITH MULTIPLE SCLEROSIS; CMSC-ACTRIMS May 2013; Tracy Flemming, Bess Martin, Clinton Reeves, Rehabilitation, Tanner Center for MS, Birmingham, AL

EVOKED POTENTIALS AND NEUROPSYCHOLOGICAL TESTS VALIDATE POSITRON EMISSION TOPOGRAPHY (PET) BRAIN METABOLISM IN COGNITIVLY IMPAIRED PATIENTS; PLOS ONE, 1 March 2013, Volume 8, Issue 3; Eric R. Braverman, et.al.

TREATMENT OF COMORBID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND ANXIETY IN CHILDREN: PROCESSES OF CHANGE; Psychological Assessment (2013, February 11); Jarrett, M. A.

LOW AND NORMAL IGF-1 LEVELS IN PATIENTS WITH CHRONIC MEDICAL DISORDERS (CMD) IS INDEPENDENT OF ANTERIOR PITUITARY HORMONE DEFICIENCIES: Implications for Treating IGF-1 Abnormal Deficiencies with CMD; (2013). J Genet Syndr Gene Ther 4: 123; Braverman E, Oscar- Berman M, Lohmann R, Kennedy R, Kerner M, et al.

EFFECTS OF SuperUlam ON SUPPORTING CONCENTRATION AND MOOD: A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY; Evidence-Based Complementary and Alternative Medicine 2013; Jay K Udani

DISCREPANCIES BETWEEN DEPRESSION AND ANXIETY ON A COMPUTER-BASED TASK OF VERBAL MEMORY; The Journal of Neuropsychiatry and Clinical Neurosciences 2013;25:161-166; Lokesh Shahani, Chad A. Noggle

OPEN LABEL, RANDOMIZED, CROSSOVER PILOT TRIAL OF HIGH-RESOLUTION, RELATIONAL, RESONANCE-BASED, ELETROENCEPHALIC MIRRIORING TO RELIEVE INSOMNIA; Brain Behavior. Nov 2012; 2(6): 814-824. Tegeler CH, Kumar SR, Conklin D, Lee SW, Gerdes L, Turner DP, Tegeler CL, C Fidali B, Houle TT.

COVERT HEPATIC ENCEPHALOPATHY: NOT AS MINIMUAL AS YOU MIGHT THINK; Clinical Gastroenterology and Hepatology vol. 10 issue 11 November, 2012. p. 1208-1219; Kappus, Matthew R.; Bajaj, Jasmohan S.

ESTIMATION OF THE CONTRIBUTION OF NORKETAMINE TO KETAMINE-INDUCED ACUTE PAIN RELIEF AND NEUROCOGNITIVE IMPAIRMENT IN HEALTHY VOLUNTEERS; Anesthesiology. 2012 August ; 117(2): 353-364; Erik Olofsen, MSc, Ingeborg Noppers, MD PhD, Albert Dahan, MD PhD

ADVANCES IN DESIGNS FOR ALZHEIMER'S DISEASE CLINICAL TRIALS; Am J Neurodegener Dis 2012;1(3):205-216; Jeffrey Cummings, Heath Gould, Kate Zhong

EXAMINATION OF ORG 26576, AN AMPA RECPTOR POSITIVE ALLOSTERIC MODULATOR, IN PATIENTS DIAGNOSED WITH MAJOR DEPRESSIVE DISORDER: AN EXPLORATORY, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL; J Psychopharmacol 6 September 2012; Kari R Nations, et.al.

LISDEXAMFETAMINE DIMESYLATE IN THE TREATMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH PARTIALLY OR FULLY REMITTED MAJOR DEPRESSIVE DISORDER; APA May 2012; R. Keefe, A. Boyd, M. Madhoo, R. Roth, A. Sambunaris, J. Wu, M. Trivedi, C. Anderson, R. Lasser

THE EFFECTS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND STIMULANT MEDICATIONS ON PERFORMANCE ON CONCUSSION ASSESSMENT TESTS; Journal of Athletic Training Volume 47 Number 3 (Supplement) May 2012; Littleton AC, Guskiewicz KM, Schmidt JD, Register-Mihalik JK, Gioia GA, Mihalik JP, Waicus KM

USA VALIDATED COMPUTERIZED PSYCHOMETRIC TESTING SYSTEM FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY - AT LAST; Gastroenterology Volume 142, Issue 5, Supplement 1, Page S-952, May 2012; Ravi Prakas, Rani Chikkanna, Kiran Anna, Puja Karanth, Sanath K. Allampati, Thimmaiah G. Theethira, Grace Dosanjh, Adam T. Perzynski, Kevin D. Mullen

ASSESSING THE EFFECT OF SELF-POSITIONING ON COGNITIVE EXECUTIVE FUNCTION; J Ergonomics 2012, 2:4; Schraefel et. al.

ACUTE LORAZEPAM EFFECTS ON NEUROCOGNITIVE PERFORMANCE; Epilepsy & Behavior 25 2012 329-333; David W. Loring, Susan E. Marino, David Parfitt, Glen R. Finney, Kimford J. Meador

AUTONOMIC NERVOUS SYSTEM AROUSAL AND COGNITIVE FUNCTIONING IN BIPOLAR DISEASE; Levy B; Bipolar Disord. 2012 Dec 12.

CONCURRENT VALIDITY OF CNS VITAL SIGNS IN PATIENTS WITH MILD TRAUMATIC BRAIN INJURY; American Congress of Rehabilitation Medicine 2012; Shawnda C. Lanting, PhD, Grant L. Iverson, PhD, and Rael T. Lange, PhD

COMPARING PATIENTS WITH MILD TRAUMATIC BRAIN INJURY TO TRAUMA CONTROLS ON CNS VITAL SIGNS; American Congress of Rehabilitation Medicine 2012; Shawnda C. Lanting, PhD, Grant L. Iverson, PhD, and Rael T. Lange, PhD

COGNITIVE RESCUE AND SYMPTOM REDUCING EFFECTS OF HYPERBARIC OXYGEN THERAPY ON ARMED SERVICE PERSONNEL AND CIVILIANS DIAGNOSED WITH A TRAUMATIC BRAIN INJURY: REPORT FROM THE N.B.I.R.R. STUDY; Society for Neuroscience 2012; James K. Wright, M.D., Tommy L. Love, D.O., Robert Mozeyani, M.D., Latisha Smith, M.D., Xavier A. Figueroa, Ph.D.

COMPUTERIZED NEUROPSYCHOLOGICAL TESTING IN THE MANAGEMENT OF SPORTS-RELATED CONCUSSIONS; Athletic Training & Sports Health Care 2012; David Bica, DO; Joseph Armen, DO; and Brock Niceler, MD

DIAGNOSTIC CONFIRMATION OF MILD TRAUMATIC BRAIN INJURY BY DIFFUSION TENSOR IMAGING: A CASE REPORT; Journal of Medical Case Reports 2012; Ranga Krishna, Michael Grinn, Nicholas Giordano, Magesh Thirunavukkarasu, Prasanna Tadi, Shibani Das

STRUCTURAL BRAIN DIFFERENCES IN BREAST CANCER PATIENTS COMPARED TO MATCHED CONTROLS PRIOR TO CHEMOTHERAPY; International Journal of Biology 2012; Carole Scherling, Barbara Collins, Joyce MacKenzie, Chris Lepage, Catherine Bielajew & Andra Smith

AQUIRED CHROMOSOMAL CHANGES IN LYMPHOCYTES ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION (CD) PRIOR TO CHEMOTHERAPY IN WOMEN WITH BREAST CANCER (BC); National State of the Science Congress on Nursing Research 2012 Abstract; Debra E Lyon, Ronald K Elswick, Noran Aboalela, Timothy York, Y-J Chen, Nancy L Mccain, Lynne Elmore, Angela Starkweather, Colleen Jackson-Cook

POLYMORPHISMS OF APOLIPOPPROTEIN E GENE AND COGNITIVE FUNCTIONS OF POSTMENOPAUSAL WOMEN, MEASURED BY A BATTERY OF COMPUTER TESTS - CENTRAL NERVOUS SYSTEM VITAL SIGNS; Neuro Endocrinol Lett. 2012 Aug 31; Bojar I, Wojcik-Fatla A, Owoc A, Lewinski A.

RECOVERY TO NEUROCOGNITIVE BASELINE AFTER ACUTE ETHANOL INTOXICATION; ISCTM 2012; Chandiramani DV, Goddard SD, Boyd AF, Udani J.

COMPARING PARTICIPANT-REPORTED MEMORY PROBLEMS WITH MEMORY PERFORMANCE TESTS IN CHRONIC MARIJUANA USERS; NCDEU 2012; Boyd AF, Morgan, DW, Goddard SG, Gray KM

DURATION OF MARIJUANA USE AND THE COGNITIVE IMPACT ON SIMPLE REACTION TIME; ISCTM 2012; Harrington M, Morgan DW, Goddard SG, Gray KM

THE EFFECTS OF QUERCETIN SUPPLEMENTATION ON COGNITIVE FUNCTIONING IN A COMMUNITY SAMPLE: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL; Therapeutic Advances in Psychopharmacology August 2012; Joshua J. Broman-Fulks, William H. Canu, Krystal L. Trout and David C. Nieman

RED BLOOD CELL OMEGA-3 FATTY ACID LEVELS AND NEUROCOGNITIVE PERFORMANCE IN DEPLOYED U.S. SERVICEMEMBERS; Nutritional Neuroscience 2012; Daniel T. Johnston, Patricia A. Deuster, William S. Harris, Holden MacRae, Michael N. Dretsch

EFFECT OF MERCURY LEVELS AND SEAFOOD INTAKE ON COGNITIVE FUNCTION IN MIDDLE-AGED ADULTS; Integrative Medicine, June 2012

SPEED OF INFORMATION PROCESSING NEUROREHABILITATION PROGRAM: A PILOT STUDY OF ADULTS WITH TRAUMATIC BRAIN INJURY; 2011 ESCoNS - Entertainment Software and Cognitive Neurotherapeutics Society Annual Meeting; Gerald T. Voelbel, Joseph Rath, Teresa Ashman, Tamara Bushnik, Stan Fort, Laura Miles, Coralynn Long, Kristin Szostek.

EXERCISE FREQUENCY IS RELATED TO PSYCHOPATHOLOGY BUT NOT NEUROCOGNITIVE FUNCTION; Medicine and Science in Sports and Exercise, December 2011; Amy M. Knab, David C. Nieman,

THE RELATIONSHIP BETWEEN URINE CANNABINOID CONCENTRATION AND CHOICE REACTION TIME IN CHRONIC MARIJUANA USERS; ISCTM 2012; Boyd AF, Morgan, DW, Goddard SG, Gray KM

COMPUTERIZED NEUROPSYCHOLOGICAL TESTING TO RAPIDLY EVALUATE COGNITION IN PEDIATRIC PATIENTS WITH NEUROLOGIC DISORDER; Journal of Child Neurology, January 2012; Brian L. Brooks and Elisabeth M. S. Sherman

COMPARING COMPUTERIZED COGNITIVE SCREENING TO THE MOCA IN PARKINSON'S DISEASE; M.A. Langill, G.L. Iverson, S. Gelb & A.J. Stoessl; Fortieth Annual Meeting; International Neuropsychological Society, February 15-18, 2012, Montréal, Québec, Canada

ASSESSMENT OF MILD COGNITIVE IMPAIRMENT: A COMPARITIVE STUDYAlzheimer's & Dementia (2011) 338-355; Peter J. Snyder, Colleen E. Jackson, Ronald C. Petersen, Ara S. Khachaturian, Jeffrey Kaye, Marilyn S. Albert, Sandra Weintraub

YOU CAN'T FAKE THIS: EMBEDDED VALIDITY MEASURES FOR A COMPUTERIZED COGNITIVE TEST BATTERY; UCUR Poster 2011; Glusman, Rohling, Hill, Ploetz, Womble, Shenesey; Department of Psychology, University of South Alabama, Mobile AL

EXOME SEQUENCING AND UNRELATED FINDINGS IN THE CONTEXT OF COMPLEX DISEASE RESEARCH: ETHICAL AND CLINICAL IMPLICATIONS; Discovery Medicine, Volume 12, Number 62, Pages 41-55, July 2011; Gholson J. Lyon, et.al.

COGNITIVE AND MOTIVATIONAL CONTRIBUTORS TO APTITUDE: A SPOKEN AND SIGNED LANGUAGE INTERPRETATING STUDENTS; Aptitude for Interpreting. Special issue of Interpreting 13:1 (2011); Sherry Shaw

TEST-RETEST RELIABILITY AND EFFORT ON THE CNS Vital Signs ASSESSMENT; Poster presented at the 39th (2011) Annual Meeting of the International Neuropsychological Society. Boston, MA; Jones, R., Francis, J., Baum, L., & Sautter, S.

EXERCISE FREQUENCY IS RELATED TO PSYCHOPATHOLOGY BUT NOT NEUROCOGNITIVE FUNCTION; Medicine and Science in Sports and Exercise, December 2011; Amy M. Knab, David C. Nieman, Joshua J. Broman-Fulks, William H. Canu, and Wei Sha

HUNTINGTON'S DISEASE: TWO-YEAR OBSERVATIONAL FOLLOW-UP OF EXECUTIVE FUNCTION EVALUATION WITH CNS VITAL SIGNS TEST IN AN ADULT PATIENT; Case Reports in Medicine, Volume 2011, Article ID 385894, 4 pages; Anna Lucia Spear King, Alexandre Martins Valenc, Adriana Cardoso de Oliveira e Silva, Ana Claudia Cerqueira, L¢¥©¥giaMaria Chaves Ferraz, and Antonio Egidio Nardi

THE EFFECTS OF FEEDBACK, STATE ANXIETY, AND GENDER ON NEUROPSYCHOLOGICAL TEST PERFORMANCE; DeRight J, Jorgensen R, Lewandowski L, Ortigue S; Abstract & Poster NAN 2011

COGNITIVE/NEUROPSYCHOLOGICAL PROFILES IN LD/ADHD AND NON-DISABLED COLLEGIATE ATHLETES; Johnson L, Willingham M; Abstract and Poster NAN 2011

MEASURING CHANGE IN COGNITIVE FUNCTIONING IN OUTPATIENTS WITH DEPRESSION USING COGNITIVE SCREENING; Iverson G, McIntosh D, Kjernisted K, Young A; Abstract & Poster NAN 2011

EMBEDDED VALIDITY MEASURES FOR A COMPUTERIZED COGNITIVE TEST BATTERY; Rohling, M., Hill, B., Ploetz, D., Womble, M., Shenesey, J. & Drayer, K. L.; Poster 2011 NAN Conference

DETECTING COGNITIVE IMPAIRMENT IN PEDIATRIC NEUROLOGY PATIENTS USING THE CNS VITAL SIGNS COMPUTERIZED NEUROPSYCHOLOGICAL BATTERY; Brooks B, Sherman E; Poster; 2011 NAN Abstract & Poster

THE ROLE OF ANTIDEPRESSANT TREATMENTS ON COGNITIVE DEFICITS A REVIEW OF RECENT LITERATURE; Clinical Neuropsychology; 2011; 8,6,354-366; A Francomano, B Bonanno, L Fuca, M La Placa, D La Barbera.

IDENTIFYING A COGNITIVE IMPAIRMENT SUBGROUP IN ADULTS WITH MOOD DISORDERS; Grant L. Iverson, Brian L. Brooks, Scott A. Langenecker, Allan H. Young; Journal of Affective Disorders, 2011 Aug; 132(3):360-7

AGGRESSIVE EVALUATION, MANAGEMENT AND MONITORING OF MCI/DEMENTIA SYNDROMES; Donald E. Schmechel, MD, April Jacob, PA-C, Annette Beam, RN and Alan Boyd, RPh; International Congress of Alzheimer's Disease; Paris, France; July 2011

A PROSPECTIVE DOSE-RESPONSE STUDY OF THE EFFECTS OF CHEMOTHERAPY ON COGNITION IN EARLY-STAGE BREAST CANCER PATIENTS; B Collins, J MacKenzie, GA Tasca, L Weiss, A Smith, C Scherling; Poster: MASCC/ISOO Athens, Greece; June 2011

EXAMINING THE PREDICTIVE VALIDITY OF COMPUTER ADMINSTERED NEUROPSYCHOLOGICAL ASSESSMENT ON CPAP TREATMENT ADHERENCE IN ADULTS DIAGNOSED WITH OBSTRUCTIVE SLEEP APNEA; Armstrong, L., Glidewell, R., Orr, W., & Roby, E.; The Clinical Neuropsychologist, Jul 2011Poster presented at Division 40 APA Washington, D.C.

THE UTILITY OF USING THE APNEA-HYPOPNEA INDEX AND COMPUTER ADMINSTERED NEUROPSYCHOLOGICAL TESTING TO PREDICT CPAP TREATMENT ADHERENCE: A RETROSPECTIVE ANALYSIS; Armstrong, L., Glidewell, R., Orr, W., & Roby, E. (2011). Journal of Sleep and Sleep Disorders Research, 34, 136-13

PILOT ASSESSMENT OF COMPUTERIZED NEUROPSYCHOMETRIC MEASURES IN PARTIAL SLEEP DEPRIVATION; St. Louis EK, Dueffert LG, Dresow MW, Calvin A, Bukartyk J, Somers VK; SLEEP Mtg. June 2011

A METHODOLOGY FOR ASSESSING TREATMENT RESPONSE IN HASIMOTO ENCEPHALOPATHY: A CASE STUDY DEMONSTRATING REPEATED COMPUTERIZED NEUROPSYCHOLOGICAL TESTING; Journal of Child Neurology, February 10, 2011; Brian L. Brooks PhD, and Karen M. Barlow, MB, ChB, MRCPCH

NEUROCOGNITION PERFORMANCE AND SELF-REPORTED SEDATION FOLLOWING ADMINSTRATION OF LORAZEPAM; Yen-Revollo, JL, Boyd, AF, Loring, DW, Meador, KJ; ISCTM, February 2011

PSYCHOMETRIC CRITERIA FOR IDENTIFYING COGNITIVE IMPAIRMENT IN OLDER ADULTS ON CNS VITAL SIGNS; Grant L. Iverson, Ph.D., Brian Brooks, Ph.D., Copeman Neuroscience Centre, University of British Columbia., Alberta Children's Hospital, University of Calgary; INS 2011

TEST-RETEST RELIABILITY AND EFFORT ON THE CNS VITAL SIGNS ASSESSMENT; Poster presented at the 39th Annual Meeting of the International Neuropsychological Society. Boston (2011), MA.; Jones, R., Francis, J., Baum, L., & Sautter, S.

ASSESSMENT AND REHABILITATION OF COGNITIVE IMPAREMENT IN MUTIPLE SCLEROSIS; International Review of Psychiatry, February 2010; LAMBROS MESSINIS, MARY H. KOSMIDIS, EPAMEINONDAS LYROS, & PANAGIOTIS PAPATHANASOPOULOS

HERITABILITY IN COGNITIVE PERFORMANCE IN LARGE-SCALE STUDIES CAN BE ASSESSED BY COMPUTER-BASED TESTING; ISCTM 2010; Aaron S. Hervey PhD, Kathryn Greenfield, Sandeep Vaishnavi MD PhD, C. Thomas Gualtieri MD

COMPUTERIZED PSYCHOMETRIC TESTING FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY; Prakash R, Anna K, Chikkanna R, Karanth P, Gulati D, Dosanjh G, Iduru S, Mullen K.D; MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; ISHEN 2010

HASHIMOTO'S ENCEPHALOPATHY: A PEDIATRIC CASE STUDY WITH PRE- AND POST-TREATMENT NEUROPSYCHOLOGICAL TESTING; Brian L. Brooks, Taryn B. Fay, Karen M. Barlow; Alberta Children's Hospital, University of Calgary; 2010 Annual Meeting Abstracts / Archives of Clinical Neuropsychology 25 (2010): 479

TRADITIONAL VERSUS COMPUTERIZED FINGER TAPPING IN PATIENTS WITH PARKINSON'S DISEASE; Langill M, Roberts R, Iverson G, Appel-Cresswell S, Stoessl A; 2010 Annual Meeting Abstracts / Archives of Clinical Neuropsychology 25 (2010): 539

THE NEUROCOGNITIVE PROFILE OF PATIENTS WITH MAJOR DEPRESSION WITH AND WITHOUT CARDIOVASCULAR RISK FACTORS COMPARED TO MILD DEMENTIA PATIENTS; Sandeep Vaishnavi, MD, PhD & C. Thomas Gualtieri, MD, NC Neuropsychiatry Chapel Hill, Raleigh, Charlotte, North Carolina; ICAD 2010, USA; Dexter Morgan, CNS Vital Signs; International Congress of Alzheimer's Disease 2010

THE UTILITY OF A COMPUTERIZED TEST BATTERY FOR THE MEASUREMENT OF COGNITIVE PERFORMANCE IN OBSTRUCTIVE SLEEP APNEA; Glidewell, R, Roby, E. Helm, K., Orr, W.; Lynn Institute of the Rockies, Colorado Springs, CO; Lynn Institute for Healthcare Research, Oklahoma City, OK; SLEEP 2010

EFFECTS ON COGNITION OF ADJUNCTIVE ZIPRASIDONE VERSUS PLACEBO IN A LONGTERM RANDOMIZED, DOUBLE BLIND TRIAL IN SUBJECTS WITH BIPOLAR I DISORDER; Elizabeth Pappadopulos, Ph.D., Richard Keefe, M.D., Onur Karayal, M.D., Francine Mandel, Ph.D., Doug Vanderburg, M.D., Sonya Lewis Ph.D., Michelle Stewart, Ph.D.; 163rd Annual Meeting of the American Psychiatric Association; 2010 May 22-26; New Orleans, LA

COMPUTERIZED NEUROCOGNITIVE TESTING IN ADULT SICKLE CELL PATIENTS; Crawford, R., Feliu, M. H., Edwards, C., & Telen, Duke University Medical Center, Durham, NC; 31st annual meeting of the Society of Behavioral Medicine, Seattle, WA

A CONDENSED VERSION OF COMPUTERIZED NEUROCOGNITIVE TESTING CAN DIFFERENTIATE BETWEEN CONTROLS, DEPRESSION, MILD COGNITIVE IMPAIRMENT, AND DEMENTIA; Sandeep Vaishnavi, MD, PhD & C. Thomas Gualtieri, MD; NC Neuropsychiatry; ANPA 2010

COMPUTERIZED NEUROCOGNITIVE TESTING; C Thomas Gualtieri MD, North Carolina Neuropsychiatry Clinics; Brain Injury March 2010

MEASURES OF COGNITIVE FUNCTION AND WORK IN OCCUPATIONALLY ACTIVE BREAST CANCER SURVIVORS; Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M.; J Occup Environ Med. 2010 Feb;52(2):219-27.

IDENTIFYING COGNITIVE PROBLEMS IN CHILDREN AND ADOLESCENTS WITH DEPRESSION USING COMPUTERIZED NEUROPSYCHOLOGICAL TESTING; Brian L. Brooks; Grant L. Iverson; Elisabeth M. S. Sherman; Marie-Claude Roberge, Neurosciences, Alberta Children's Hospital, Calgary, Canada Departments of Pediatrics and Clinical Neurosciences, University of Calgary, Calgary, Canada Department of Psychiatry, University of British Columbia, Vancouver, Canada d British Columbia Mental Health & Addiction Services, Coquitlam, Canada e University of Ottawa, Ottawa, Canada; Applied Neuropsychology, 08 February 2010.

IDENTIFYING COGNITIVE IMPAIRMENT IN CHILDREN WITH MOOD DISORDERS USING COMPUTERIZED TESTING; Grant L. Iverson, University of British Columbia & British Columbia Mental Health & Addiction Services, Brian L. Brooks, Alberta Children's Hospital & University of Calgary; Presented at: International Neuropsychological Society, February, 2010, Acapulco, Mexico.

IDENTIFYING COGNITIVE IMPAIRMENT IN ADULTS WITH MOOD DISORDERS USING COMPUTERIZED TESTING; Grant L. Iverson, University of British Columbia & British Columbia Mental Health & Addiction Services, Brian L. Brooks, Alberta Children's Hospital & University of Calgary; Presented at: International Neuropsychological Society, February, 2010, Acapulco, Mexico.

ASSOCIATION BETWEEN DEPRESSION SEVERITY AND NEUROCOGNITIVE FUNCTION IN MAJOR DEPRESSIVE DISORDER: A REVIEW AND SYNTHESIS; Neuropsychology 2010, Vol. 24, No. 1, 9-34; S McClintock M Husain, T Greer, and C M Cullum

Use of a Computer Based Neurocognitive Software Program in Asymptomatic Neurologically Intact Adults with Sickle Cell Disease; ASH 2009; Regina D. Crawford, M.D., Miriam Feliu, PhD, Christopher L. Edwards, PhD and Marilyn J. Telen, MD

A 3-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ASENAPINE IN THE TREATMENT OF ACUTE MANIA IN BIBOLAR MANIA AND MIXED STATES; Roger S McIntyre, Miriam Cohen, Jun Zhao, Larry Alphs, Thomas A Macek and John Panagides; Bipolar Disorders 2009: 11: 673-686

RAPID ASSESSMENT OF NEUROCOGNITIVE DEFICITS IN BIPOLAR DISORDER; Iverson, G. L., Brooks, B. L., Ashton, V. L., Johnson, L. G., & Gualtieri, C. T. ; APPLIED NEUROPSYCHOLOGY, 16: 207-213, 2009

OPERATIONALIZING COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA: MATRICS CONSENSUS COGNITIVE BATTERY AND ALTERNATIVES; M. Stewart, Ph.D., M. Stolar, Ph.D., Sally Olderbak, M.A., R. Goldman, Ph.D., and E. Watsky, M.D.; International Congress on Schizophrenia Research, San Diego, CA, USA, March 28-April 1, 2009

AEROBIC EXERCISE ENHANCES COGNITIVE FLEXIBILITY; Masley S, Roetzheim R, Gualtieri T.; J Clin Psychol Med Settings (2009) 16:186-193

COMPUTERIZED NEUROPSYCHOLOGICAL BATTERY DETECTS PSYCHOMOTOR PROCESSING SPEED IMPAIRMENT AS THE CORE COGNITIVE DEFICIT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS; Messinis L., PhD., Anyfantis E., M.Sc., Lyros E., MD, PhD., Papathanasopoulos P., MD, PhD; Department of Neurology, Neuropsychology Section, University of Patras Medical School, Thessaloniki, Greece, 29 January 1st Febrauary 2009

HIGHER COGNITIVELY FUNCTIONING RELAPSING-REMITTING MUTIPLE SCLEROSIS PATIENTS HAVE A MORE SPECIFIC PATTERN OF IMPAIRMENT ON NEUROPSYCHOLOGICAL TESTING; Sandeep Vaishnavi, MD, PhD, John Barkenbus, MD, C. Thomas Gualtieri, MD; NC Neuropsychiatry; Raleigh & Charlotte, NC; AAN 2009

DIFFERENTIATING MALINGERERS AND PATIENTS WITH CONVERSION DISORDER USING A COMPUTERIZED NEUROCOGNITIVE ASSESSMENT BATTERY; C Thomas Gualtieri MD Sandeep Vaishnavi MD PhD Aaron Hervey PhD; American Neuropsychiatric Association, March, 2009.

NEUROCOGNITIVE EVALUATION OF PATIENTS WITH TRAUMATIC BRAIN INJURIES; C Thomas Gualtieri MD Sandeep Vaishnavi MD PhD; North Carolina Neuropsychiatry Clinics, Chapel Hill, Charlotte & Raleigh; ISCTM Feb. 2009

NEUROFEEDBACK IMPROVES EXECUTIVE FUNCTIONING IN CHILDREN WITH AUTISM SPECTRUM DISORDERS; Mirjam E.J. Kouijzer, Jan M.H. de Moor, Berrie J.L. Gerrits, Marco Congedo, Hein T. van Schie ; Research in Autism Spectrum Disorders; Volume 3, Issue 1, January 2009, Pages 145-162

MEDICATIONS DO NOT NECESSARILY NORMALIZE COGNITION IN AD/HD PATIENTS; C.Thomas Gualtieri and Lynda G. Johnson; Journal of Attention Disorders 2008; Winner of the 2008 MHS Keith Conners Award for Scholarly contribution to the field of attention-deficit disorder.

ASSESSMENT OF FIBROMYALGIA & CHRONIC FATIGUE SYNDROME: A NEW PROTOCOL DESIGNED TO DETERMINE WORK CAPABILITY-CHRONIC PAIN ABILITIES DETERMINATION (CPAD).; Kelly M, Gagne R, Newman JD, Olney C, Gualtieri C, Trail D.; Irish Medical Journal. 2008 Oct;101(9):277-8.

DOES FAMILIARITY WITH COMPUTERS AFFECT COMPUTERIZED NEUROPSYCHOLOGICAL TEST PERFORMANCE?; Grant L. Iverson, Brian L. Brooks, V. Lynn Ashton, Lynda G. Johnson, C. Thomas Gualtieri; Journal of Clinical and Experimental Neuropsychology, October 2008

SENSITIVITY & SPECIFICITY OF COMPUTERIZED TESTING FOR MCI; C Thomas Gualtieri MD, Alan Boyd PharmD; ICAD - International Congress for Alzheimer's Disease, July, 2008.

AN INVESTIGATION OF THE IMPACT OF PSYCHOLOGICAL TRAUMA ON THE NEUROPSYCHOLOGICAL FUNCTIONING OF SCHOOL AGED CHILDREN; Hosford, D. J., & Stuart, A. D; Poster 2008, 43rd Annual Conference of the Australian Psychological Society (pp. 44-45)

THE FREQUENCY OF COGNITIVE IMPAIRMENT IN PATIENTS WITH ANXIETY, DEPRESSION, AND BIPOLAR DISORDER: AN UNACCOUNTED SOURCE OF VARIANCE IN CLINICAL TRIALS; Gualtieri CT, Morgan DW.; Journal of Clinical Psychiatry. 2008 Jul;69(7):1122-30.

PSYCHOMOTOR SPEED IMPAIRMENT AS MAIN COGNITIVE DYSFUNCTION IN RELAPSING-REMITTING MULTIPLE SCLEROSIS; Maimone D, Zappalà G, Matta F, Aiello D, Bianca M, Papale B, Pavone A, Gualtieri T *Neurology Unit, Garibaldi Hospital, Catania - ITALY; *CNS Vital Signs, Chapel Hill, NC - USA

Comparison of Two Fully Computerized Cognitive Test Batteries to the MATRICS, Consensus Cognitive Battery, M. Stewart, Ph.D.1; R. Goldman, Ph.D.2, Ph.D.; M. Stolar, Ph.D.1; E. Watsky, M.D.1; M. Versavel, M.D.3; and W. Moritz, B.S.1 Pfizer Global Research & Development, NCDEU 2008 Boca Raton Fl

EFFICACY OF LIFESTYLE CHANGES IN MODIFYING PRACTICAL MARKERS OF WELLNESS AND AGING; Masley, S. C., Weaver, W., Peri, G., & Phillips, S. E; Altern Ther Health Med. 2008 Mar-Apr;14(2):24-9.

COMPUTERIZED TEST BATTERY SENSITIVE TO MILD AND SEVERE BRAIN INJURY; C. Thomas Gualtieri, MD; Lynda G. Johnson, PhD; Medscape J Med. 2008;10(4):90.

SHORT FORM OF CNS VITAL SIGNS FOR USE IN DEPRESSION; International Neuropsychological Society February 2008; Grant L. Iverson, Brian L. Brooks, Allan H. Young, University of British Columbia & British Columbia Mental Health & Addiction Services, British Columbia Mental Health & Addiction Services, University of British Columbia.

CNS VITAL SIGNS (CNSVS) AS A TOOL TO SCREEN FOR ADHD/LD IN STUDENT ATHLETES; International Neuropsychological Society February 2008; Gualtieri & Johnson, North Carolina Neuropsychiatry

AGE-RELATED COGNITIVE DECLINE IN PATIENTS WITH MOOD DISORDERS; C. Thomas Gualtieri, Lynda G. Johnson; Departments of Neuropsychiatry and Neuropsychology, North Carolina Neuropsychiatry Clinics, Chapel Hill & Charlotte, United States; Progress in Neuro-Psychopharmacology & Biological Psychiatry 32 (2008) 962-967

STATUS OF COMPUTERIZED COGNITIVE TESTING IN AGING: A SYSTEMATIC REVIEW; Katherine Wild, Diane Howiesona, Frank Webbeb, Adriana Seelyea, Jeffrey Kaye; Layton Aging and Alzheimer Center, Oregon Health and Science University, Portland, OR, USA, Florida Institute of Technology, Melbourne, FL, USA; Alzheimer's & Dementia 4 (2008) 428-437

CLINICAL USEFULNESS OF CNS VITAL SIGNS FOR ASSESSING NEUROCOGNITION IN ADHD - CHILDREN; APA 2007; Grant L. Iverson, Brian L. Brooks, Margaret D. Weiss, Lynda G. Johnson, & C. Thomas Gualtieri.

PREVALENCE OF NEUROCOGNITIVE DEFICITS IN ADULTS WITH UNTREATED AD/HD: IMPLICATIONS FOR THE WORKPLACE, APA 2007; Brian L. Brooks1, Grant L. Iverson2,1, Margaret D. Weiss2,3, C. Thomas Gualtieri4,& Lynda G. Johnson4; 1British Columbia Mental Health & Addiction Services, 2University of British Columbia, 3British Columbia Provincial ADHD Program, 4 North Carolina Neuropsychiatry Clinic.

IDENTIFYING FRANK NEUROCOGNITIVE IMPAIRMENT WITH CNS VITAL SIGNS IN PATIENTS WITH UNTREATED DEPPRESSION; APA 2007; Grant L. Iverson, Brian L. Brooks, Allan H. Young, Lynda G. Johnson, & C. Thomas Gualtieri.

ADULTS WITH UNTREATED MOOD DISORDERS HAVE NEUROCOGNITIVE DEFICITS THAT CAN IMPACT WORKPLACE PERFORMANCE, American Psychiatric Association 2007; Brian L. Brooks1, Grant L. Iverson 2, Allan H. Young 2, Lynda G. Johnson 3,& C. Thomas Gualtieri 3; 1 British Columbia Mental Health & Addiction Services, 2 University of British Columbia, 3 North Carolina Neuropsychiatry Clinics.

USING THE CNS VITAL SIGNS COMPUTERIZED BATTERY FOR ASSESSING NEUROCOGNITION IN ADULTS WITH UNTREATED AD/HD, American Psychological Association 2007; Grant L. Iverson, Brian L. Brooks, Margaret D. Weiss, C. Thomas Gualtieri & Lynda G. Johnson, University of British Columbia, British Columbia Mental Health & Addiction Services, British Columbia Provincial ADHD Program, North Carolina Neuropsychiatry Clinics.

RAPID ASSESSMENT OF NEUROCOGNITIVE DEFICITS IN BIPOLAR DISEASE; Society of Biological Psychiatry 2007; Grant L. Iverson, University of British Columbia & British Columbia Mental Health & Addiction Services, Brian L. Brooks, British Columbia Mental Health & Addiction Services, Allan H. Young, University of British Columbia, Lynda G. Johnson & C. Thomas Gualtieri, North Carolina Neuropsychiatry.

RELIABILITY AND VALIDITY OF A COMPUTERIZED NEUROCOGNITIVE TEST BATTERY, CNS VITAL SIGNS; Archives Clinical Neuropsychology; September 30, 2006.

NEUROPSYCHOLOGICAL FUNCTIONING AND OROS® METHYLPHENIDATE IN AN ADULT ATTENTION-DEFICIT / HYPERACTIVITY DISORDER (ADHD) POPULATION; 46th Annual Meeting of the New Clinical Drug Evaluation Unit June 14, 2006; Fred W. Reimherr, MD; Barrie K. Marchant, MS; Robert E. Strong, DO; Poonam Soni, MD; Garrett Burbidge, BA; Erika Williams, MSW; University of Utah, Salt Lake City, Utah

COMPUTERIZED COGNITIVE TEST PERFORMANCE IN COMPUTER USER AND NON-USER OLDER ADULTS; Patricia C. Heyn, PhD, Tammie Nakamura., MS, Rosa A. Tang, MD, MPH, Robin Sun School of Medicine, University of Colorado at Denver & Health Sciences Center Neuro-Ophthalmology of Texas, University of Houston, Texas.

NEUROCOGNITION IN DEPRESSION: PATIENTS ON AND OFF MEDICATION VERSUS HEALTHY COMPARISON SUBJECTS. C. Thomas Gualtieri, M.D.; Lynda G. Johnson, Ph.D.; Kenneth B. Benedict, M.D.; J Neuropsychiatry Clinical Neuroscience; 2006 Spring; 18(2):217-25.

ANTIDEPRESSANT SIDE EFFECTS IN CHILDREN AND ADOLESCENTS; J Child Adolescent Psychopharmacology 2006 Feb-Apr; 16(1-2):147-57.

EFFICIENT ALLOCATION OF ATTENTIONAL RESOURCES IN PATIENTS WITH AD/HD: MATURATIONAL CHANGES FROM AGE 10 TO 29; Journal of Attention Disorders Volume 9 Number 3; February 2006 Pub Med

NEUROCOGNITIVE TESTING SUPPORTS A BROADER CONCEPT OF MILD COGNITIVE IMPAIRMENT American Journal of Alzheimer's Disease and Other Dementias; Volume 20, Number 6, November/December 2005. Pub Med

NEUROPSYCHOLOGY AND FATIGUE: Expanding the spectrum of executive functions impairment in patients with multiple sclerosis by a computerised neuropsychological tests battery. Source: D. Maimone, G. Zappalà (Catania, I) Thursday, September 29, 2005; 21st Congress of the European Committee for the Treatment and Research in Multiple Sclerosis; 10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis; 28.09.2005 - 01.10.2005

CNS VITAL SIGNS CNS (CNSVS) PERFORMANCE OF ADD PATIENTS ON AND OFF STIMULANT MEDICATION, L Johnson & T Gualtieri, Poster Abstract National Academy of Neuropsychology conference; Tampa October 19-22 2005

A PRACTICAL APPROACH TO OBJECTIVE AD/HD DIAGNOSIS AND MANAGEMENT, PSYCHOLOGY 2005, JULY 2005

DIFFERENTIATING BETWEEN MILD COGNITIVE IMPAIRMENT AND EARLY DEMENTIA WITH A NEW, COMPUTERIZED NEUROCOGNITIVE ASSESSMENT BATTERY Symposium on Dementia Screening (II), Alzheimer's Association International Conference on Prevention of Dementia, Washington DC, June, 2005.

COMPARATIVE NEUROCOGNITIVE EFFECTS OF FIVE PSYCHOTROPIC ANTICONVULSANTS AND LITHIUM; American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005

NEUROCOGNITIVE TESTING SUPPORTS A BROADER CONCEPT OF MILD COGNITIVE IMPAIRMENT American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005

USING CNS VITAL SIGNS IN DETECTION OF EARLY DEMENTIA AND MILD COGNITIVE IMPAIRMENT; Fülöp Emõke, Kurimay Tamás, Zákány Ildikó, Dénes Eszter, Tamás Erzsébet; 8th Hungarian Congress on Alzheimer Clin Neurosci/Ideggy Szle 2004;57(9-10):322-343

A COMPUTERIZED COGNITIVE ASSESSMENT BATTERY FOR PSYCHIATRISTS American Psychiatric Association, Annual Meeting, New York, NY May 2004.

THE COMPARATIVE NEUROCOGNITIVE EFFECTS OF SEVEN ANTIDEPRESSANTS; American Psychiatric Association Annual Meeting, New York, NY May, 2004.

PSYCHOMETRIC AND CLINICAL PROPERTIES OF A NEW, COMPUTERIZED NEUROCOGNITIVE ASSESSMENT BATTERY American Neuropsychiatric Association Annual Meeting, Bal Harbor, FL Feb. 24, 2004.

RELIABILITY AND VALIDITY OF A NEW COMPUTERIZED COGNITIVE ASSESSMENT BATTERY International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004

COGNITIVE PERFORMANCE IN BIPOLAR AND UNIPOLAR DEPRESSION; International Neuropsychological Society Annual Meeting, Baltimore, MD Feb. 6, 2004

DRUG SENSITIVITY OF A COMPUTERIZED NEUROCOGNITIVE TEST BATTERY; International Neuropsychological Society Annual Meeting, Baltimore, MD February 6, 2004

DEMENTIA ASSESSMENT USING COMPUTERIZED TESTS; J Insur Med 36, 213-227, 2004.

DEMENTIA ASSESSMENT IN LIGHT OF THE DIVERSITY OF THE CONDITION.

COMPUTERIZED NEUROCOGNITIVE TESTING AND ITS POTENTIAL FOR MODERN PSYCHIATRY; Psychiatry 2004.

COMPARATIVE NEUROCOGNITIVE PERFORMANCE OF PATIENTS ON ANTIDEPRESSANTS.

NEUROCOGNITION IN DEPRESSION: PATIENTS ON AND OFF MEDICATION, COMPARED TO NORMAL CONTROLS

52°³±¹¿¡¼­ 9000¸íÀÌ ³Ñ´Â ÀÇ»çµé°ú ¿¬±¸¿øµéÀÌ ½Å°æ ÀÎÁö ±â´ÉÀ» °Ë»çÇϱâ À§ÇØ CNS Vital Signs¸¦ »ç¿ëÇÏ°í ÀÖ½À´Ï´Ù. CNS Vital Signs´Â ÀÇ»çµé°ú °úÇÐÀÚµéÀÇ Çù·ÂÀÇ µµ¿òÀ» ¹Þ¾Æ Àü»êÈ­µÈ ½Å°æ ÀÎÁö °Ë»ç¿¡ °üÇÑ Áö½Ä°ú ÀÀ¿ë ¹æ¹ýÀ» ¹ß°ßÇÏ°í È®Àå½ÃÅ°´Â ¿¬±¸ È°µ¿¿¡ Áö¼ÓÀûÀ¸·Î °ü¿©ÇÏ°í ÀÖ½À´Ï´Ù.

CNS Vital Signs´Â °úÇÐ Çмú ¹ßǥȸ¿¡¼­ ³í¹®, Æ÷½ºÅÍ ¹× ¹ßÇ¥·Î »óÀ» ¹ÞÀº ¸î¸îÀÇ °í°´µéÀÇ µµ¿òÀ¸·Î ¿¬±¸ÀûÀ¸·Î ¿ì¼öÇÑ À¯»êÀ» º¸À¯ÇÏ°í ÀÖ½À´Ï´Ù.

´ÙÀ½ ÃâÆǹ°µé°ú ¸µÅ©µéÀº Áõ°¡ÇÏ°í ÀÖ´Â ¿ì¸®ÀÇ ÀÓ»óÀû Áö½ÄÀÇ °ßº»ÀÔ´Ï´Ù.


¾Õ¼­°¡´Â ±â¼ú·Â°ú ³ëÇÏ¿ì! ºê·¹Àξ¾Å©¸´ÀÌ 21¼¼±â¸¦ ¾ÕÀå¼­°Ú½À´Ï´Ù.